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Inconsistency of IRB Review: a 
Research Project  
 
Sarah Fowler-Dixon, PhD 
Washington University School of Medicine 




2004 National Conference, April 19, 2004 
“The Team” 
• Sarah Fowler-Dixon Frankel, PhD 
– Specialty: curriculum & instruction 
 
• Melissa Torres, MSW(c) 
– Specialty: social/behavioral methodology 
 
• Morgan Taylor 
– Specialty: research ethics 
What We Already Know 
IRB reviews are inconsistent 
What We Want to Know 
 Can the training  
IRB members  
receive reduce  
inconsistency? 
Evolution of Orientation at WU 
• Oral discussions  
– handouts in a large notebook 
• Large notebook reorganized 
– All the HSC guidelines, federal & ethical codes were 
covered 
• Folder 
– Mock protocol included 
• Folder and Website 
– Information on-line shown 
– Still includes mock protocol 
 
Background 
• Majority of reviewers come from a biomedical 
background. 
 
• HSC full boards have difficulty understanding 
social/behavioral research. 
 
• Reviewers are divided into New Protocol Committee, 
Subcommittee, Continuing Review Committee 
 
• All data collected anonymously. 
The Study Design 
• One mock protocol 
– social/behavioral & biomedical aspects 
• New member orientation 
• 2 Parts 
– Part I: Notes taken after review of mock protocol 
– Part II: Orientation is modified based on findings 
• 2 Groups 
– New IRB members – waiver of consent 
– Existing IRB members – letter/implied consent 
Part I Orientation 
• 1 1/2 to 2 hours 
 
• Provides practical experience with the mock 
protocol 
 
• Emphasizes selected material 
 
• 74 reviewers took part 
First ½ hour 
Bathrooms/parking/vitae 
Information in notebook/authorization 
Committee structure - Recusing 
Ethical Codes:  Belmont Report 3 principles 
Sensitive Information 
Data Monitoring 






Second ½ hour 
In respective committee groups, review 
protocol 
 
Third ½ hour 
As a whole, discuss pertinent parts of 
protocol.  Begin with NPC, SUB, CRC. 
Findings 
• Problems with: 
– Benefit 
• Types of benefit 
 
– Deception research 
• Deliberate or omission 
 
– Voting  




• Did well identifying: 
– Equitable subject selection 
– Confidentiality and how that should be maintained 
– Sensitive information 
– Methodology 
• Drug testing 
– Consent omissions 
 
Part II Orientation 
• 3 hours 
• Provides practical experience with mock 
protocol 
• Emphasizes the Belmont Report 
– Providing a global context rather than individual 
pieces 
• Uses website – so more visuals 






Levine/Informed Consent books 
general announcements 
Committee structure  
3 Committees 
Number of primary reviewers 
Personal Conflict of Interest - stressed 
Recusing 
     
Contact before a committee meeting 
Staff review after a committee meeting 
Ethical & Federal Codes - mention 
Common Rule: 45 CFR 46 
FDA Protection of Human Subjects: 21 CFR 50 
FDA Establishment of IRB: 21 CFR 56 
Nuremberg Code 
Declaration of Helsinki 
Belmont Report – emphasize 
 
Respect for Persons 
 Informed consent 
  a. 8 elements of consent 
  b. alteration/exclusion of elements – K forms 
  
 Vulnerable Populations 
  a. Minors – consent/assent  
  b. Third Parties 
 
Beneficence 
 1. Risk vs. Benefit 
  a. Research Risk – use Assessing Risk Guideline 
   1. minimal risk 
   2. greater than minimal risk 




 2. Methodology 
  a. Types of Research: social/behavioral & biomedical 
  b. Deception studies 
  c. Statistical analysis 
  d. Use of investigational drugs/devices 
  e. Standard questionnaires vs. other questionnaires 
       
  3. Data Monitoring – Use Data Monitoring Guideline 
  a. Committee vs Plan  
   1. Plan can have more than one person monitor 
  
        4. Confidentiality  
  a. Types of coding and what that means 
  b. Sensitive Information 
  c. COC, what it is and when it’s needed. 
 
Justice 
       1. Equitable Subject Selection 
  a. inclusion/exclusion criteria 
 
11. Voting on the Protocol and what that means/does not mean 
 a. Approve 
 b. Approve with contingencies 
 c. Back to Committee 
 d. Disapprove – no benefit 
12. Presenting the Protocol – Use Reviewer’s Sheet 
 a. what to discuss 
13. Contents of Notebook 
 
Second ½ hour 
1. Starting the review – consent form then protocol then forms 
2. Discrepancy between forms and protocol, go with protocol and ask PI to   
    verify contents of protocol 
3. In respective committee groups, review protocol 
 
Second ½ hour 
1.  As a whole, discuss pertinent parts of protocol.   
     a. Begin with NPC, SUB, CRC. 
Preliminary Findings – Part II 
• Still collecting data 
• Thus far 
– Reviewers have a better understanding of benefit 
 
– More objective review 
 
– Use of disapproval and meaning of approve with 
contingencies 
 
Preliminary Findings – Part II 
• Concerns that remain the same from  
   Part I 
 
– Drug testing 
– Possible deception 
– Handling of confidentiality 
– Sensitivity of questionnaire 
 
What does this prove? 
• Reviews will never be completely consistent. 
 
• How we educate/do not educate our 
reviewers does matter and influences 
protocol review. 
 Future Research 
 Randomize new members to two groups of 
orientation to see which is more effective and 
how it influences the review.  
 
 Which is more influential, orientation or 
committee chair? 
 
 
